CJC-1295 No DAC (MOD GRF 1-29) 2mg – 100 Vials at 50% Off

Revo Peptide is proud to supply CJC-1295 No DAC (MOD GRF 1-29) at greater than 99% purity, rigorously verified by HPLC and mass spectrometry. Available in a high-value bulk configuration, this listing represents an outstanding opportunity for research institutions and laboratory procurement teams seeking a reliable, analytically confirmed peptide source at a significantly reduced per-unit cost. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

CJC-1295 No DAC, also referred to as MOD GRF 1-29, is a synthetic 29-amino acid analogue of endogenous growth hormone-releasing hormone (GHRH). Unlike its DAC-containing counterpart, this variant does not incorporate a Drug Affinity Complex, resulting in a shorter active half-life that makes it a preferred model compound in studies requiring precise temporal control over GHRH receptor interaction dynamics. Revo Peptide’s bulk 100-vial format is engineered for high-throughput research workflows where consistency, purity, and cost efficiency are equally critical.

Peptide Structure & Amino Acid Sequence

The full amino acid sequence of CJC-1295 No DAC (MOD GRF 1-29) is:

H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

This sequence incorporates four strategic amino acid substitutions relative to native GHRH(1-29), including the substitution of D-Alanine at position 2, which confers enhanced enzymatic stability and improved receptor binding characteristics relevant to in vitro and in vivo research models. The C-terminal amidation further contributes to the peptide’s resistance to exopeptidase degradation, making it a structurally robust research tool.

Chemical & Physical Characteristics

• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight: 3,367.79 g/mol
• Appearance: White lyophilized powder
• Solubility: Soluble in aqueous buffers and sterile water
• Unit Size: 2 mg per vial
• Peptide Purity: >99%

The peptide’s well-characterized physicochemical profile makes it suitable for a broad spectrum of laboratory assays, including receptor binding studies, cell-based functional assays, and pharmacokinetic modeling in preclinical research contexts.

Purity & Analytical Verification (HPLC & MS)

Every batch of CJC-1295 No DAC (MOD GRF 1-29) supplied by Revo Peptide undergoes stringent analytical testing prior to release. High-performance liquid chromatography (HPLC) is used to confirm peptide purity at greater than 99%, while mass spectrometry (MS) validates the correct molecular weight and sequence integrity. Certificates of Analysis (CoA) are available upon request and serve as the primary documentation of batch-level quality assurance. Researchers can be confident that each vial in this 100-unit bulk order meets the same exacting analytical standards.

Quality Control & Lyophilization Integrity

Revo Peptide employs pharmaceutical-grade lyophilization processes to convert the peptide from solution into a stable, dry powder format. This freeze-drying methodology removes residual moisture to levels that preserve peptide integrity over extended storage periods. Each vial is individually sealed under inert conditions to prevent oxidation, contamination, and moisture ingress. Bulk orders are subject to the same quality control protocols applied to single-unit shipments, ensuring batch-to-batch reproducibility across all 100 vials.

Safety, Handling & Laboratory Precautions

CJC-1295 No DAC (MOD GRF 1-29) is supplied exclusively for qualified research use in controlled laboratory environments. Personnel handling this compound should adhere to standard laboratory safety protocols, including the use of appropriate personal protective equipment (PPE) such as gloves, lab coat, and eye protection. This peptide must not be administered to humans or animals under any circumstances. Proper biohazard disposal procedures should be followed in accordance with local institutional and regulatory guidelines.

Reconstitution, Packaging & Storage

For laboratory reconstitution purposes, researchers should consult peer-reviewed literature and institutional SOPs relevant to their specific assay requirements. Upon receipt, vials should be stored at −20°C in a frost-free freezer, away from direct light and humidity. Once reconstituted, solutions should be aliquoted and stored at 4°C for short-term use. The lyophilized powder format provides superior long-term stability compared to pre-dissolved peptide solutions. This bulk order is packaged to maintain cold-chain integrity throughout transit.

Intended Research Use & Market Positioning

CJC-1295 No DAC (MOD GRF 1-29) is one of the most extensively referenced GHRH analogues in academic and preclinical literature. It is widely used in studies examining growth hormone secretagogue receptor pathways, pulsatile GH release modeling, neuroendocrine signaling, and metabolic research frameworks. Revo Peptide’s 100-vial bulk format is specifically positioned for institutional buyers, contract research organizations (CROs), and academic laboratories conducting large-scale or longitudinal studies that demand consistent peptide quality at a competitive price point.

Ordering, Availability & Fulfillment

This 100-vial bulk listing of CJC-1295 No DAC (MOD GRF 1-29) is available to order now directly through Revo Peptide at 50% off the standard per-vial price, representing significant savings for qualifying research buyers. Our fulfillment process is optimized for speed and compliance, with orders processed promptly and shipped with appropriate cold-chain packaging. Buy online today and take advantage of the best price available on bulk research-grade MOD GRF 1-29 from a trusted supplier committed to analytical transparency and research integrity.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. CJC-1295 No DAC (MOD GRF 1-29) is sold strictly as a laboratory research compound. Revo Peptide makes no claims regarding therapeutic efficacy, safety for administration, or suitability for any use outside of controlled scientific research. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international laws and regulations governing the acquisition, possession, and use of research peptides. This product is intended for use by qualified researchers and licensed institutions only.